Cameron Durrant

Track

Insider profile

Currently holds a position at Humanigen Inc

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Humanigen Inc Sept. 5, 2017 -
Lead Independent Director Immune Pharmaceuticals Inc Jan. 21, 2015 - Sept. 10, 2018
Chairman of the Board, Chief Executive Officer, interim Chief Financial Officer Humanigen Inc Aug. 11, 2017 - Sept. 5, 2017
Chairman of the Board, Chief Executive Officer Humanigen Inc March 3, 2016 - Aug. 11, 2017
Independent Chairman of the Board Humanigen Inc Jan. 11, 2016 - March 3, 2016
Independent Director Immune Pharmaceuticals Inc July 10, 2014 - Jan. 21, 2015
President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, Director OncBioMune Pharmaceuticals Inc Oct. 31, 2012 - Aug. 7, 2013
President, Chief Executive Officer, Director OncBioMune Pharmaceuticals Inc Nov. 17, 2010 - Oct. 31, 2012
Cameron Durrant's trades of Humanigen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Humanigen Inc (HGEN)
Transaction date
Purchase
Price
219.17
Quantity 43,453 +35.9%
Value US$3,940,924
US Humanigen Inc (HGEN)
Transaction date
Sale
Price
214.82
Quantity 12,805 +17.7%
Value US$4,684,803
US Humanigen Inc (HGEN)
Transaction date
Sale
Price
164.33
Quantity 60,617 -36.0%
Value US$2,489,513
US Humanigen Inc (HGEN)
Transaction date
Sale
Price
20.60
Quantity 26,441 -23.7%
Value US$544,685
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-04 2022-03-02
US Humanigen Inc (HGEN)
B Purchase
43,453 +35.9%
219.17
US$3,940,924 		43,453 +35.9% 219.17 US$3,940,924
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
12,805 +17.7%
214.82
US$4,684,803 		12,805 +17.7% 214.82 US$4,684,803
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
60,617 -36.0%
164.33
US$2,489,513 		60,617 -36.0% 164.33 US$2,489,513
2021-06-16 2021-06-14
US Humanigen Inc (HGEN)
S Sale
26,441 -23.7%
20.60
US$544,685 		26,441 -23.7% 20.60 US$544,685